RG
BSX icon

Renaissance Group’s Boston Scientific BSX Stock Holding History

Renaissance Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-276,752
Closed -$17.4M – 241
2026
Q1 		$17.4M Sell
276,752
-17,572
-6% -$1.41M 0.73% 54
2025
Q4 		$28.1M Buy
+294,324
New +$28.9M 1.13% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Group's BSX Position: Q2 2026 in Review

Renaissance Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 276,752 shares — an estimated $17.4M sold.

Renaissance Group first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $28.1M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Renaissance Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Renaissance Group sold 276,752 Boston Scientific shares in Q2 2026, an estimated $17.4M.
  • Renaissance Group first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Renaissance Group's Boston Scientific position peaked at $28.1M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.